Fulgent Genetics (FLGT)
(Delayed Data from NSDQ)
$18.53 USD
+1.35 (7.86%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $18.52 -0.01 (-0.05%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth D Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
FLGT 18.53 +1.35(7.86%)
Will FLGT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for FLGT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for FLGT
Fulgent Genetics, Inc. (FLGT) Surpasses Q2 Earnings and Revenue Estimates
Fulgent Genetics, Inc. (FLGT) Q1 Earnings and Revenues Beat Estimates
FLGT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Hims & Hers Health (HIMS) Moves 5.7% Higher: Will This Strength Last?
Fulgent Genetics, Inc. (FLGT) Q4 Earnings and Revenues Beat Estimates
TruBridge (TBRG) Soars 6.4%: Is Further Upside Left in the Stock?
Other News for FLGT
Fulgent Genetics Inc (FLGT) Q2 2025 Earnings Call Highlights: Strong Core Revenue Growth Amid ...
Q2 2025 Fulgent Genetics Inc Earnings Call Transcript
Fulgent Genetics lifts 2025 revenue outlook to $320M and narrows EPS loss guidance while advancing clinical pipeline
Fulgent Genetics, Inc. (FLGT) Q2 2025 Earnings Call Transcript
Fulgent Genetics, Inc. 2025 Q2 - Results - Earnings Call Presentation